[1] [1] LINASK K K. The heart-placenta axis in the first month of pregnancy: induction and prevention of cardiovascular birth defects［J］.Journal of Pregnancy, 2013, 2013: 320413.LINASK K K. The heart-placenta axis in the first month of pregnancy: induction and prevention of cardiovascular birth defects［J］.Journal of Pregnancy, 2013, 2013: 320413.

[2] [2] COPP A J, GREENE N D. Neural tube defects-disorders of neurulation and related embryonic processes［J］. Wiley InterdisciplinaryReviews: Developmental Biology, 2013, 2(2): 213-227.

[3] [3] HOLMES L B, DRISCOLL S G, ATKINS L. Etiologic heterogeneity of neural-tube defects［J］. The New England Journal of Medicine, 1976, 294(7): 365-369.

[4] [4] DETRAIT E R, GEORGE T M, ETCHEVERS H C, et al. Humanneural tube defects: developmental biology, epidemiology, andgenetics［J］. Neurotoxicol Teratol, 2005, 27(3): 515-524.

[5] [5] KOURY M J, PONKA P. New insights into erythropoiesis: theroles of folate, vitamin B12, and iron［J］. Annual Review of Nutrition, 2004, 24: 105-131.

[6] [6] ZHU H, WLODARCZYK B J, SCOTT M, et al. Cardiovascularabnormalities in Folr1 knockout mice and folate rescue［J］. BirthDefects Research Part A: Clinical and Molecular Teratology, 2007,79(4): 257-268.

[7] [7] HAN M, SERRANO M C, LASTRA-VICENTE R, et al. Folaterescues lithium, homocysteine and Wnt3A-induced vertebratecardiac anomalies［J］. Disease Models & Mechanisms, 2009,2(9/10): 467-478.

[8] [8] LINASK K K, HUHTA J. Folate protection from congenital heartdefects linked with canonical Wnt signaling and epigenetics［J］.Current Opinion in Pediatrics, 2010, 22(5): 561-566.

[9] [9] HUHTA J C, LINASK K. When should we prescribe high-dose folic acid to prevent congenital heart defects?［J］. Current Opinionin Cardiology, 2015, 30(1): 125-131.

[10] [10] CRIDER K S, YANG T P, BERRY R J, et al. Folate and DNAmethylation: a review of molecular mechanisms and the evidencefor folate’s role［J］. Advances in Nutrition, 2012, 3(1): 21-38.

[11] [11] SHULPEKOVA Y, NECHAEV V, KARDASHEVA S, et al. Theconcept of folic acid in health and disease［J］. Molecules, 2021,26(12): 1-29.

[12] [12] ZHAO R, DIOP-BOVE N, VISENTIN M, et al. Mechanisms ofmembrane transport of folates into cells and across epithelia［J］.Annual Review of Nutrition, 2011, 31: 177-201.

[13] [13] SEELAN R S, MUKHOPADHYAY P, PHILIPOSE J, et al. Gestational folate deficiency alters embryonic gene expression and cellfunction［J］. Differentiation, 2021, 117: 1-15.

[14] [14] NAWAZ F Z, KIPREOS E T. Emerging roles for folate receptorFOLR1 in signaling and cancer［J］. Trends Endocrinol Metab,2022, 33(3): 159-174.

[15] [15] SPIEGELSTEIN O, EUDY J D, FINNELL R H. Identification oftwo putative novel folate receptor genes in humans and mouse［J］.Gene, 2000, 258(1/2): 117-125.

[16] [16] PIEDRAHITA J A, OETAMA B, BENNETT G D, et al. Micelacking the folic acid-binding protein Folbp1 are defective inearly embryonic development［J］. Nature Genetics, 1999, 23(2):228-232.

[17] [17] TANG L S, WLODARCZYK B J, SANTILLANO D R, et al.Developmental consequences of abnormal folate transport during murine heart morphogenesis［J］. Birth Defects Research PartA: Clinical and Molecular Teratology, 2004, 70(7): 449-458.

[18] [18] CHINNERY H R, MCMENAMIN P G, DANDO S J. Macrophagephysiology in the eye［J］. Pflugers Archiv: European Journal ofPhysiology, 2017, 469(3/4): 501-515.

[19] [19] XIA W, HILGENBRINK A R, MATTESON E L, et al. A functional folate receptor is induced during macrophage activation andcan be used to target drugs to activated macrophages［J］. Blood,2009, 113(2): 438-446.

[20] [20] ROSARIO F J, POWELL T L, JANSSON T. Mechanistic target ofrapamycin (mTOR) regulates trophoblast folate uptake by modulating the cell surface expression of FR-α and the RFC［J］. Scientific Reports, 2016, 6: 1-11.

[21] [21] TANG L S, SANTILLANO D R, WLODARCZYK B J, et al. Roleof folbp1 in the regional regulation of apoptosis and cell proliferation in the developing neural tube and craniofacies［J］. AmericanJournal of Medical Genetics Part C: Seminars in Medical Genetics,2005, 135(1): 48-58.

[22] [22] GELINEAU-VAN W J, HELLER S, BAUER L K, et al. Embryonic development in the reduced folate carrier knockout mouse ismodulated by maternal folate supplementation［J］. Birth DefectsResearch Part A: Clinical and Molecular Teratology, 2008, 82(7):494-507.

[23] [23] KULKARNI A, WILSON D M. The involvement of DNA-damageand repair defects in neurological dysfunction［J］. American Journal of Human Genetics, 2008, 82(3): 539-566.

[24] [24] ALBINO D, BRIZZOLARA A, MORETTI S, et al. Gene expression profiling identifies eleven DNA repair genes down-regulatedduring mouse neural crest cell migration［J］. The InternationalJournal of Developmental Biology, 2011, 55(1): 65-72.

[25] [25] WANG X, YU J, WANG J. Neural tube defects and folate deficiency: is DNA repair defective?［J］. International Journal of Molecular Sciences, 2023, 24(3): 1-15.

[26] [26] OKANO M, BELL D W, HABER D A, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylationand mammalian development［J］. Cell, 1999, 99(3): 247-257.

[27] [27] WANNER N, VORNWEG J, COMBES A, et al. DNA methyltransferase 1 controls nephron progenitor cell renewal and differentiation［J］. Journal of the American Society of Nephrology:JASN, 2019, 30(1): 63-78.

[28] [28] LI S Y, PARK J, GUAN Y, et al. DNMT1 in Six2 progenitor cellsis essential for transposable element silencing and kidney development［J］. Journal of the American Society of Nephrology: JASN,2019, 30(4): 594-609.

[29] [29] LI E, BESTOR T H, JAENISCH R. Targeted mutation of the DNAmethyltransferase gene results in embryonic lethality［J］. Cell,1992, 69(6): 915-926.

[30] [30] LY A, ISHIGURO L, KIM D, et al. Maternal folic acid supplementation modulates DNA methylation and gene expression in therat offspring in a gestation period dependent and organ-specificmanner［J］. The Journal of Nutritional Biochemistry, 2016, 33:103-110.

[31] [31] HAN X, CAO X, CABRERA R M, et al. Folate regulation of planar cell polarity pathway and F-actin through folate receptor alpha［J］. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 2024, 38(1): 1-16.

[32] [32] LU X L, WANG L, CHANG S Y, et al. Sonic hedgehog signaling affected by promoter hypermethylation induces aberrant Gli2expression in spina bifida［J］. Molecular Neurobiology, 2016,53(8): 5413-5424.

[33] [33] LI J, XIE Q, GAO J, et al. Aberrant Gcm1 expression mediatesWnt/β-catenin pathway activation in folate deficiency involved inneural tube defects［J］. Cell Death & Disease, 2021, 12(3): 1-16.

[34] [34] CZEIZEL A E, DUDAS I, VERECZKEY A, et al. Folate deficiency and folic acid supplementation: the prevention of neural-tubedefects and congenital heart defects［J］. Nutrients, 2013, 5(11):4760-4775.

[35] [35] RAGHUBEER S, MATSHA T E. Methylenetetrahydrofolate(MTHFR), the one-carbon cycle, and cardiovascular risks［J］. Nutrients, 2021, 13(12): 1-15.

[36] [36] BOOT M J, STEEGERS-THEUNISSEN R P, POELMANN R E,et al. Cardiac outflow tract malformations in chick embryos exposed to homocysteine［J］. Cardiovascular Research, 2004, 64(2):365-373.

[37] [37] VANMIL N H, OOSTERBAAN A M, STEEGERS-THEUNISSENR P M. Teratogenicity and underlying mechanisms of homocysteine in animal models: a review［J］. Reproductive Toxicology,2010, 30(4): 520-531.

[38] [38] MIKAEL L G, DENG L, PAUL L, et al. Moderately high intake offolic acid has a negative impact on mouse embryonic development［J］. Birth Defects Research Part A: Clinical and Molecular Teratology, 2013, 97(1): 47-52.

[39] [39] PICKELL L, BROWN K, LI D, et al. High intake of folic acid disrupts embryonic development in mice［J］. Birth Defects ResearchPart A: Clinical and Molecular Teratology, 2011, 91(1): 8-19.

[40] [40] KINTAKA Y, WADA N, SHIODA S, et al. Excessive folic acidsupplementation in pregnant mice impairs insulin secretion andinduces the expression of genes associated with fatty liver in theiroffspring［J］. Heliyon, 2020, 6(4): 1-8.

[41] [41] BUIJTENDIJK M F J, BARNETT P, VAN DEN HOFF M J B.Development of the human heart［J］. American Journal of Medical Genetics Part C, Seminars in Medical Genetics, 2020, 184(1):7-22.

[42] [42] LIN L, CUI L, ZHOU W, et al. Beta-catenin directly regulatesIslet1 expression in cardiovascular progenitors and is required formultiple aspects of cardiogenesis［J］. Proceedings of the NationalAcademy of Sciences of the United States of America, 2007,104(22): 9313-9318.

[43] [43] HAN X, WANG B, JIN D, et al. Precise dose of folic acid supplementation is essential for embryonic heart development in zebrafish［J］. Biology (Basel), 2021, 11(1): 1-15.

[44] [44] TYAGI R, VERMA S, DASH N, et al. Folate deficiency: a possible association with congenital heart defects［J］. Indian Journalof Pediatrics, 2022, 89(10): 1013-1015.

[45] [45] TORRENS C, BRAWLEY L, ANTHONY F W, et al. Folatesupplementation during pregnancy improves offspring cardiovascular dysfunction induced by protein restriction［J］. Hypertension,2006, 47(5): 982-987.

[46] [46] CZEIZEL A E, DUDAS I, VERECZKEY A, et al. Folate deficiency and folic acid supplementation: the prevention of neural-tubedefects and congenital heart defects［J］. Nutrients, 2013, 5(11):4760-4775.

[47] [47] SMITH S B, KEKUDA R, GU X, et al. Expression of folate receptor alpha in the mammalian retinol pigmented epithelium andretina［J］. Investigative Ophthalmology & Visual Science, 1999,40(5): 840-848.

[48] [48] BRIDGES C C, El-SHERBENY A, ROON P, et al. A comparisonof caveolae and caveolin-1 to folate receptor alpha in retina andretinal pigment epithelium［J］. The Histochemical Journal, 2001,33(3): 149-158.

[49] [49] BOZARD B R, GANAPATHY P S, DUPLANTIER J, et al. Molecular and biochemical characterization of folate transport proteins in retinal Müller cells［J］. Investigative Ophthalmology &Visual Science, 2010, 51(6): 3226-3235.

[50] [50] JWALA J, BODDU S H, PATURI D K, et al. Functional characterization of folate transport proteins in staten’s seruminstitutrabbit corneal epithelial cell line［J］. Current Eye Research, 2011,36(5): 404-416.

[51] [51] GANAPATHY P S, MOISTER B, ROON P, et al. Endogenouselevation of homocysteine induces retinal neuron death in thecystathionine-beta-synthase mutant mouse［J］. Investigative Ophthalmology & Visual Science, 2009, 50(9): 4460-4470.

[52] [52] AJITH T A, RANIMENON. Homocysteine in ocular diseases［J］.Clinica Chimica Acta, 2015, 450: 316-321.

[53] [53] WRIGHT A D, MARTIN N, DODSON P M. Homocysteine, folates, and the eye［J］. Eye, 2008, 22(8): 989-993.

[54] [54] SPIEGELSTEIN O, MITCHELL L E, MERRIWEATHER M Y,et al. Embryonic development of folate binding protein-1 (Folbp1)knockout mice: effects of the chemical form, dose, and timing ofmaternal folate supplementation［J］. Developmental Dynamics:An Official Publication of the American Association of Anatomists, 2004, 231(1): 221-231.

[55] [55] SIJILMASSI O. Folic acid deficiency and vision: a review［J］.Graefe’s Archive for Clinical and Experimental Ophthalmology,2019, 257(8): 1573-1580.

[56] [56] SIJILMASSI O, DEL R S A, MALDONADO B E, et al. Gestational folic acid deficiency alters embryonic eye development:possible role of basement membrane proteins in eye malformations［J］. Nutrition, 2021, 90: 1-8.

[57] [57] KEULS R A, FINNELL R H, PARCHEM R J. Maternal metabolism influences neural tube closure［J］. Trends in Endocrinology& Metabolism, 2023, 34(9): 539-553.

[58] [58] SATO K. Why is folate effective in preventing neural tube closuredefects?［J］. Medical Hypotheses, 2020, 134: 1-4.

[59] [59] BlOM H J, SHAW G M, DEN H M, et al. Neural tube defects andfolate: case far from closed［J］. Nature Reviews Neuroscience,2006, 7(9): 724-731.

[60] [60] LIU Y, YUAN Q, WANG Z, et al. A high level of KLF12 causesfolic acid-resistant neural tube defects by activating the Shh signaling pathway in mice［J］. Biology of Reproduction, 2021, 105(4):837-845.

[61] [61] ISKANDAR B J, NELSON A, RESNICK D, et al. Folic acid supplementation enhances repair of the adult central nervous system［J］. Annals of Neurology, 2004, 56(2): 221-227.

[62] [62] CHON J, FIELD M S, STOVER P J. Deoxyuracil in DNA anddisease: genomic signal or managed situation?［J］. DNA Repair(Amst), 2019, 77: 36-44.

[63] [63] LYU X, ZHOU D, GE B, et al. Association of folate metabolitesand mitochondrial function in peripheral blood cells in Alzheimer’sdisease: a matched case-control study［J］. Journal of Alzheimer’sDisease: JAD, 2019, 70(4): 1133-1142.

[64] [64] PEI P, CHENG X, YU J, et al. Folate deficiency induced H2Aubiquitination to lead to downregulated expression of genes involved in neural tube defects［J］. Epigenetics Chromatin, 2019,12(1): 1-19.

[65] [65] ICHI S, COSTA F F, BISCHOF J M, et al. Folic acid remodelschromatin on Hes1 and Neurog2 promoters during caudal neuraltube development［J］. The Journal of Biological Chemistry, 2010,285(47): 36922-36932.

[66] [66] WANG L, SHANGGUAN S, XIN Y, et al. Folate deficiency disturbs hsa-let-7g level through methylation regulation in neural tubedefects［J］. Journal of Cellular and Molecular Medicine, 2017,21(12): 3244-3253.

[67] [67] SHOOKHOFF J M, GALLICANO G I. A new perspective onneural tube defects: folic acid and microRNA misexpression［J］.Genesis, 2010, 48(5): 282-294.

[68] [68] GUPTA I R, LAPOINTE M, YU O H. Morphogenesis duringmouse embryonic kidney explant culture［J］. Kidney International, 2003, 63(1): 365-376.

[69] [69] POZZI A, COFFA S, BULUS N, et al. H-Ras, R-Ras, and TC21differentially regulate ureteric bud cell branching morphogenesis［J］. Molecular Biology of The Cell, 2006, 17(4): 2046-2056.

[70] [70] HIDA M, OMORI S, AWAZU M. ERK and p38 MAP kinase arerequired for rat renal development［J］. Kidney International,2002, 61(4): 1252-1262.

[71] [71] FISHER C E, MICHAEL L, BARNETT M W, et al. Erk MAP kinase regulates branching morphogenesis in the developing mousekidney［J］. Development, 2001, 128(21): 4329-4338.

[72] [72] HENRY T Q, MANSANO R Z, NAST C C, et al. GDNF andMAPK-ERK pathway signaling is reduced during nephrogenesisfollowing maternal under-nutrition［J］. Journal of DevelopmentalOrigins of Health and Disease, 2010, 1(1): 67-74.

[73] [73] TANG M J, CAI Y, TSAI S J, et al. Ureteric bud outgrowth inresponse to RET activation is mediated by phosphatidylinositol3-kinase［J］. Developmental Biology, 2002, 243(1): 128-136.

[74] [74] KUURE S, POPSUEVA A, JAKOBSON M, et al. Glycogen synthase kinase-3 inactivation and stabilization of beta-catenin inducenephron differentiation in isolated mouse and rat kidney mesenchymes［J］. Journal of the American Society of Nephrology:JASN, 2007, 18(4): 1130-1139.

[75] [75] HALT K, VAINIO S. Coordination of kidney organogenesis bywnt signaling［J］. Pediatric Nephrology (Berlin, Germany), 2014,29(4): 737-744.

[76] [76] BIRN H, SPIEGELSTEIN O, CHRISTENSEN E I, et al. Renaltubular reabsorption of folate mediated by folate binding protein 1［J］. Journal of the American Society of Nephrology: JASN, 2005,16(3): 608-615.

[77] [77] AWAZU M, HIDA M. Maternal nutrient restriction inhibits ureteric bud branching but does not affect the duration of nephrogenesis in rats［J］. Pediatric Research, 2015, 77(5): 633-639.

[78] [78] MACLENNAN N K, JAMES S J, MELNYK S, et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism,and histone acetylation in IUGR rats［J］. Physiological Genomics,2004, 18(1): 43-50.

[79] [79] AWAZU M, HIDA M. Folic acid supplementation alleviates reduced ureteric branching, nephrogenesis, and global DNA methylation induced by maternal nutrient restriction in rat embryonickidney［J］. PLoS One, 2020, 15(4): 1-13.